Ironwood And Vectivbio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of Vectivbio
Acquiring Company
Ironwood Pharmaceuticals
Acquired Company
VectivBio
BostonBiotechnologyHealth CareMedicalBiotechnologyHealth CareScience And EngineeringDescription
Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Ironwood’s pending acquisition of VectivBio, expired at 11:59 p.m., Eastern Time, on June 15, 2023.
Quick answer
Ironwood Pharmaceuticals is acquiring VectivBio, announced June 16, 2023. Ironwood Pharmaceuticals is based in Boston, Massachusetts, United States.
- How much did Ironwood Pharmaceuticals pay for VectivBio?
- The deal value was not disclosed.
- What does Ironwood Pharmaceuticals do?
- Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI..
- Where are Ironwood Pharmaceuticals and VectivBio based?
- Ironwood Pharmaceuticals is based in Boston, Massachusetts, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Science And Engineering
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Vivo Infusion Acquires Specialty Infusion Centers (June 20, 2023)
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Serb Pharmaceuticals Acquires Vistogard® And Xuriden® From Wellstat Therapeutics (July 13, 2023)
- Astellas Completes Acquisition Of Iveric Bio (July 11, 2023)
- Thermo Fisher Scientific To Acquire Corevitas (July 6, 2023)
- Lilly To Acquire Sigilon Therapeutics (June 29, 2023)
Who to call at Ironwood Pharmaceuticals, and when
When Ironwood Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Ironwood Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ironwood Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ironwood Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ironwood Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired VectivBio?
VectivBio was acquired by Ironwood Pharmaceuticals, based in Boston. The deal was reported on June 16, 2023. Ironwood Pharmaceuticals is publicly traded (IRWD) and operates in Biotechnology.
When did Ironwood Pharmaceuticals acquire VectivBio?
Ironwood Pharmaceuticals's acquisition of VectivBio was reported on June 16, 2023. Ironwood Pharmaceuticals, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does VectivBio do?
VectivBio (Nasdaq: VECT) is a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.